Webinar | How Will Microbiome Reshape Anti-Aging Skin Care in 2026 Register Here

Episteme Prognostics

Episteme Prognostics is a precision medicine company developing therapeutic biomarkers for pancreatic cancer.
2019
New York, New York, United States

Investment Funding

Last Funding Stage

Seed

Total Funding Amount

4.11M

Last Funding Amount

4.11M

Last Funding Date

13-04-2023

Startup Stage

Seed

People

Founders

Something missing or incorrect on this page? Help us enrich this information